Literature DB >> 8376933

Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10.

K Frei1, D Nadal, H W Pfister, A Fontana.   

Abstract

The killing of bacteria gaining access to the central nervous system is insufficient and requires bactericidal antibiotics for treatment. The inefficient host response in cerebrospinal fluid (CSF) is thought to be due to impaired phagocytosis in CSF, and low local concentration of antibody and complement. In addition, the CSF may contain inhibitors, disabling phagocytes to eliminate bacteria. We have assessed the bactericidal activity of macrophages in the presence of CSF from mice infected intracerebrally with Listeria monocytogenes (LM). Pretreatment of J774A.1 macrophages with interferon gamma (IFN-gamma) resulted in high levels of nitric oxide-dependent intracellular killing of LM. CSF taken from mice 24 h after infection (CSF-LM 24) contained IFN-gamma and induced killing of LM by macrophages. However, pulsing J774A.1 cells with IFN-gamma in the presence of CSF obtained from mice at later time points (48 h) rendered macrophages partly permissive for intracellular Listeria growth. The inhibitor detected in CSF-LM 48 was identified as IL-10 since: (a) IL-10 dose dependently impaired the listericidal activity of IFN-gamma-activated macrophages; (b) anti-IL-10 antibodies abrogated the bacterial growth permissive effect of CSF-LM 48; and (c) IL-10 was detected in CSF-LM 48 but not in CSF-LM 24 or CSF of mock-injected animals (CSF-Co). Likewise, IL-10 was found in the CSF of 95% of patients with bacterial meningitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376933      PMCID: PMC2191197          DOI: 10.1084/jem.178.4.1255

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

Review 1.  Bacterial meningitis in the patient at risk: intrinsic risk factors and host defense mechanisms.

Authors:  W M Scheld
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

2.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

3.  Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes.

Authors:  S E Malawista; R R Montgomery; G van Blaricom
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo.

Authors:  K Frei; D Piani; U V Malipiero; E Van Meir; N de Tribolet; A Fontana
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

5.  The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis.

Authors:  K Saukkonen; S Sande; C Cioffe; S Wolpe; B Sherry; A Cerami; E Tuomanen
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

6.  Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.

Authors:  A Waage; A Halstensen; R Shalaby; P Brandtzaeg; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

7.  Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation.

Authors:  O Ramilo; X Sáez-Llorens; J Mertsola; H Jafari; K D Olsen; E J Hansen; M Yoshinaga; S Ohkawara; H Nariuchi; G H McCracken
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

8.  Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

Authors:  C Gérard; C Bruyns; A Marchant; D Abramowicz; P Vandenabeele; A Delvaux; W Fiers; M Goldman; T Velu
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

9.  Interleukin 10: a novel stimulatory factor for mast cells and their progenitors.

Authors:  L Thompson-Snipes; V Dhar; M W Bond; T R Mosmann; K W Moore; D M Rennick
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  23 in total

1.  Use of corticosteroids and other adjunct therapies for acute bacterial meningitis in adults.

Authors:  Kameshwar Prasad; Nirendra Kumar Rai; Amit Kumar
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis.

Authors:  P F Stahel; K Frei; A Fontana; H P Eugster; B H Ault; S R Barnum
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 3.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

Authors:  A M van Furth; J J Roord; R van Furth
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis.

Authors:  M Deckert; S Soltek; G Geginat; S Lütjen; M Montesinos-Rongen; H Hof; D Schlüter
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  Fatal Meningitis in Swine after Intrathecal Administration of Adeno-associated Virus Expressing Syngeneic Interleukin-10.

Authors:  Mark D Unger; Josef Pleticha; James E Collins; Anibal G Armien; Jennifer L Brazzell; Laura K Newman; Lukas F Heilmann; Jodi A Scholz; Timothy P Maus; Andreas S Beutler
Journal:  Mol Ther       Date:  2017-08-01       Impact factor: 11.454

Review 6.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

7.  Cerebrospinal fluid affects phenotype and functions of myeloid dendritic cells.

Authors:  M Pashenkov; M Söderström; Y-M Huang; H Link
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

8.  Entry of Listeria monocytogenes into neurons occurs by cell-to-cell spread: an in vitro study.

Authors:  S Dramsi; S Lévi; A Triller; P Cossart
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Phosphatidylcholine-specific phospholipase C from Listeria monocytogenes is an important virulence factor in murine cerebral listeriosis.

Authors:  D Schlüter; E Domann; C Buck; T Hain; H Hof; T Chakraborty; M Deckert-Schlüter
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Bacterial meningitis: epidemiology, pathogenesis and management update.

Authors:  Yuliya Nudelman; Allan R Tunkel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.